Showing 3221-3230 of 7016 results for "".
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/distinguishing-first-line-treatment-adverse-event-profiles-in-her2-negative-upper-gi-cancers/37691/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingDeep Learner: Building AI to Improve Cardiovascular Care
https://reachmd.com/programs/medical-industry-feature/deep-learner-building-ai-to-improve-cardiovascular-care/18093/Tune in to learn how machine learning technologies could be key to the future of medicine, providing doctors more time to care for their patients.Does Working the Night Shift Increase the Risk of Heart Disease in Women?
https://reachmd.com/programs/the-jama-report/does-working-night-shift-increase-risk-heart-disease-women/8081/New research from JAMA suggests that rotating night shift work is associated with modest risk of coronary heart disease in women.Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods
https://reachmd.com/programs/the-jama-report/rates-obesity-and-diabetes-lower-more-walkable-neighborhoods/8158/A study found neighborhoods that were more walkable experienced a slower increase in obesity and diabetes compared to less walkable neighborhoods.Challenge Case Report: Acute Onset of Expressive Aphasia, Visual Disturbances, and Severe Headache
https://reachmd.com/programs/practical-neurology/challenge-case-report-acute-onset-of-expressive-aphasia-visual-disturbances-and-severe-headache/33146/The differential diagnosis in the setting of leptomeningeal enhancement is broad, but when seen in association with an expansile intraparenchymal mass, there should be high suspicion for a neoplastic process.Closing Gaps in Care for People of Color with Psoriatic Disease
https://reachmd.com/programs/practical-dermatology/closing-gaps-in-care-for-people-of-color-with-psoriatic-disease/18190/Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocatePersonalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
https://reachmd.com/programs/medical-industry-feature/personalizing-pnh-care-iptacopan/35650/While patients with paroxysmal nocturnal hemoglobinuria (PNH) share the same diagnosis, they show a range of hemoglobin levels and symptoms.1,2 C5 inhibitors have reduced mortality and morbidity in patients with PNH, but FABHALTA® (iptacopan) may offer another treatment option that can match individUnmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
https://reachmd.com/programs/cme/unmet-needs-in-endocrine-therapy-rethinking-the-hrher2-mbc-treatment-roadmap/39797/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
https://reachmd.com/programs/project-oncology/aat-c-terminal-peptides-show-independent-prognostic-value-in-early-stage-nsclc/39032/Why CELMoDs Matter in Myeloma
https://reachmd.com/programs/cme/why-celmods-matter-in-myeloma/36558/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma Activity